PedAM
Pediatric Disease Annotations & Medicines
| Disease | myeloid leukemia |
| Phenotype | C0023448|lymphoblastic leukemia |
| Sentences | 3 |
| PubMedID- 25196855 | The cumulative incidence of emr was 4.0% at 3 years, and the incidence was higher in acute lymphoblastic leukemia patients compared with acute myeloid leukemia patients (5.6% versus 2.4%). |
| PubMedID- 24891015 | However, patients with bcr-abl1(+) acute lymphoblastic leukemia and subsets of patients with chronic myeloid leukemia are at high risk of relapse despite kinase inhibition therapy, necessitating novel treatment strategies. |
| PubMedID- 24944694 | Promoter hypermethylation has also been found to reduce rtvp-1 expression in acute myeloid leukemia patients compared with lymphoblastic leukemia, chronic myeloid leukemia and remission bone marrow (11). |
Page: 1